Polypharmacy in Psychiatry Practice, Volume II Use of Polypharmacy in the "Real World" /

Despite the large number of psychotropic medications currently available, effective management of mental disorders continues to be a challenging task. Although monotherapy may be desirable, most patients require combinations of two or more psychotropic drugs. Polypharmacy aims to address different a...

Full description

Bibliographic Details
Published in:Springer eBooks
Corporate Author: SpringerLink (Online service)
Other Authors: Ritsner, Michael S. (Editor)
Format: eBook
Language:English
Published: Dordrecht : Springer Netherlands : Imprint: Springer, 2013.
Subjects:
Online Access:http://dx.doi.org/10.1007/978-94-007-5799-8
Перейти в каталог НБ ТГУ
LEADER 05087nam a22005415i 4500
001 vtls000485833
003 RU-ToGU
005 20210922065849.0
007 cr nn 008mamaa
008 140715s2013 ne | s |||| 0|eng d
020 |a 9789400757998  |9 978-94-007-5799-8 
024 7 |a 10.1007/978-94-007-5799-8  |2 doi 
035 |a to000485833 
039 9 |y 201407152002  |z Александр Эльверович Гилязов 
040 |a Springer  |c Springer  |d RU-ToGU 
050 4 |a R-RZ 
072 7 |a MBGR  |2 bicssc 
072 7 |a MED000000  |2 bisacsh 
082 0 4 |a 610  |2 23 
100 1 |a Ritsner, Michael S.  |e editor.  |9 314243 
245 1 0 |a Polypharmacy in Psychiatry Practice, Volume II  |h [electronic resource] :  |b Use of Polypharmacy in the "Real World" /  |c edited by Michael S. Ritsner. 
260 |a Dordrecht :  |b Springer Netherlands :  |b Imprint: Springer,  |c 2013.  |9 710710 
300 |a XVII, 321 p. 2 illus., 1 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a 1. Antipsychotic polypharmacy for schizophrenia: 'Secret sauce' or 'wild abandon'? -- Antipsychotic polypharmacy in USA -- Antipsychotic polypharmacy in Czech Republic and in Ukraine -- Antipsychotic polypharmacy in residential facilities in Italy: the gap between recommendations and real world practice -- Antipsychotic polypharmacy and associated phenomena in patients with schizophrenia: Rational or irrational? -- Antipsychotic polypharmacy in schizophrenia. How to counteract this common practice? -- Clozapine combinations in treatment-resistant schizophrenia patients -- Metabolic syndrome and antipsychotic polypharmacy -- Evidence based combination therapy for bipolar disorder -- Antidepressant combination strategies for major depressive disorder -- Herbal remedies and nutraceuticals as augmentation or adjunct for mood and anxiety disorders: evidence for benefit and risk -- Obsessive-compulsive syndromes in schizophrenia: A case for polypharmacy? -- Polypharmacy and potentially inappropriate medication use among elders with dementia -- The role of polypharmacy in bipolar disorder treatment guidelines. 
520 |a Despite the large number of psychotropic medications currently available, effective management of mental disorders continues to be a challenging task. Although monotherapy may be desirable, most patients require combinations of two or more psychotropic drugs. Polypharmacy aims to address different aspects of treatment resistance, especially insufficient response of positive and negative symptoms, cognitive disturbances, affective comorbidity, obsessive-compulsive syndromes and side-effects of antipsychotic agents. At the same time, evidence based guidelines in support of polypharmacy, and augmentative strategies are scant. This two-volume collection is the first comprehensive, clinically oriented, reference text on polypharmacy (co-administration of more than one medication) or the use of multiple preparations to treat psychotic, cognitive, mood and anxiety disorders. This collection is divided into four parts. Volume I contains two parts including chapters that serve as an introduction and overview of conceptual issues. Key topics include: rational polypharmacy, receptor binding targets, drug interactions, preclinical and clinical investigations in this field, dosing regimens, multiple medication use in forensic psychiatry, a naturalistic trial, adjunctive strategies, and multiple medication use for the treatment of somatic symptom disorders. Volume II contains two parts that focus on antipsychotic polypharmacy for schizophrenia, and clinical practice in the USA, Czech Republic, Ukraine, and Italy, polypharmacy and associated phenomena, clozapine combinations and the metabolic syndrome. The authors discuss combination therapy for bipolar disorder, major depressive disorder, obsessive-compulsive syndromes in schizophrenia, and potentially inappropriate medication use among elderly patients with dementia. Finally, each volume includes Appendix contains 'Annotated bibliography on polypharmacy' and 'List of Psychotropic Medications'. 
650 0 |a medicine.  |9 566220 
650 0 |a Pharmacy.  |9 299059 
650 0 |a Psychiatry.  |9 566321 
650 0 |a Psychopharmacology.  |9 302319 
650 0 |a Medical Education.  |9 307047 
650 0 |a Psychology, clinical.  |9 265970 
650 1 4 |a Biomedicine.  |9 566246 
650 2 4 |a Biomedicine general.  |9 566281 
650 2 4 |a Psychiatry.  |9 566321 
650 2 4 |a Pharmacy.  |9 299059 
650 2 4 |a Clinical Psychology.  |9 265974 
650 2 4 |a Medical Education.  |9 307047 
650 2 4 |a Psychopharmacology.  |9 302319 
710 2 |a SpringerLink (Online service)  |9 143950 
773 0 |t Springer eBooks 
856 4 0 |u http://dx.doi.org/10.1007/978-94-007-5799-8 
856 |y Перейти в каталог НБ ТГУ  |u https://koha.lib.tsu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=357013 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642) 
999 |c 357013  |d 357013